Howell Sb
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Metal complexes synthesis and properties
- Cancer Treatment and Pharmacology
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Cancer therapeutics and mechanisms 3
- DNA and Nucleic Acid Chemistry 1
- Oncology 4
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- J. Bryan Carmody (1 shared paper)Martin Haas (1 shared paper)Benjamin E. Young (1 shared paper)Stephen Cleary (1 shared paper)William E. Lucas (1 shared paper)M Markman (1 shared paper)C E Pfeifle (1 shared paper)Regis J. Weiss (1 shared paper)
- Journals
- PubMed (10 papers)
- Partner nations
- United States
In The Last Decade
Howell Sb
10 papers receiving 446 citations
Peers
Comparison fields: 5 of 74
- Oncology 250
- Reproductive Medicine 47
- Pathology and Forensic Medicine 82
- Nutrition and Dietetics 49
- Molecular Biology 214
Countries citing papers authored by Howell Sb
This map shows the geographic impact of Howell Sb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howell Sb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howell Sb more than expected).
Fields of papers citing papers by Howell Sb
This network shows the impact of papers produced by Howell Sb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howell Sb. The network helps show where Howell Sb may publish in the future.
Co-authors
The 11 scholars most cited alongside Howell Sb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. | 1990 | 367 |
| 2 | Changes in glomerular filtration rate associated with high-dose methotrexate therapy in adults. | 1977 | 23 |
| 3 | 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer. | 1982 | 22 |
| 4 | Intraperitoneal chemotherapy: the use of concurrent systemic neutralizing agents. | 1985 | 18 |
| 5 | Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin. | 1986 | 16 |
| 6 | Modulation of cytarabine uptake and toxicity by dipyridamole. | 1984 | 14 |
| 7 | Evidence against ras activation in human ovarian carcinomas. | 1987 | 11 |
| 8 | High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule. | 1982 | 11 |
| 9 | Cellular pharmacologic strategies for overcoming drug resistance: potential applications to regional therapy. | 1991 | 3 |
| 10 | Cellular resistance to platinating agents in ovarian carcinoma. | 1986 | 2 |
About Howell Sb
Howell Sb is a scholar working on Molecular Biology, Oncology, Surgery, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 10 papers that have together received 487 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), Ovarian cancer diagnosis and treatment (2 papers), Intraperitoneal and Appendiceal Malignancies (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Adenosine and Purinergic Signaling (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). The work is most often cited by research in Oncology (250 citations), Reproductive Medicine (47 citations), Pathology and Forensic Medicine (82 citations), Nutrition and Dietetics (49 citations) and Molecular Biology (214 citations). Howell Sb has collaborated with scholars based in United States. Frequent co-authors include J. Bryan Carmody, Martin Haas, Benjamin E. Young, Stephen Cleary, William E. Lucas, M Markman, C E Pfeifle, Regis J. Weiss, Seiji Isonishi and Samuel J. Mann. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.